OLIVIA SKAARE: Open Payments
NPI 1871271403 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 29 payments from 13 companies in 2025. Trend: 2023 $953 · 2024 $1,327 · 2025 $540
Food & beverage: $497Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $139 |
| Lundbeck LLC | 4 | $93 |
| Astellas Pharma US Inc | 4 | $60 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: REXULTI, Ozempic, Veozah, ENHERTU, VOQUEZNA, Wegovy, Kerendia, EPKINLY.
Industry payments across IA — which companies pay providers there.
